Skip to the page

Data / Form D filings / Stealth BioTherapeutics Corp

Stealth BioTherapeutics Corp: Form D filings

Stealth BioTherapeutics Corp, a biotechnology company in Grand Cayman, Cayman Islands, filed 2 Form D notices with the SEC between 2019 and 2020. The latest, on April 13, 2020, reports $20 million sold of a $20 million offering to 1 investor.

Find out what Stealth BioTherapeutics Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
190 ELGIN AVENUE, GEORGE TOWN, Grand Cayman, Cayman Islands, KY1-9
Phone
(617) 600-6888
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Cayman Islands
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1696396

The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 13, 2020New notice$20,000,001$20,000,001$01Apr 10, 2020sec.gov
Oct 15, 2019New notice$14,999,999$14,999,999$01Oct 10, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Lu HuangDirector
Lou LangeDirector
Edward OwensDirector
Gerald ChanDirector
Kevin McLaughlinDirector
Irene McCarthyExecutive Officer, Director
Francis ChenDirector

Every Form D from the week of Apr 13, 2020 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Stealth BioTherapeutics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.